Publications by authors named "Nathan Heald"

Claim this Profile
Q
Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophores.
Sindy Liao-Chan, Barbara Daine-Matsuoka, Nathan Heald, Tiffany Wong, Tracey Lin

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Frauke Bentzien, Marcus Zuzow, Nathan Heald, Anna Gibson, Yongchang Shi

Thyroid· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors.
James W Leahy, Chris A Buhr, Henry W B Johnson, Byung Gyu Kim, Taegon Baik, Nathan Heald

J Med Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists.
Mohamed A Ibrahim, Henry W B Johnson, Joon Won Jeong, Gary L Lewis, Xian Shi, Nathan Heald

J Med Chem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis